Contribution of factor VII, fibrinogen and fibrinolytic components to the risk of ischaemic cardiovascular disease: their genetic determinants
- 1 September 1998
- journal article
- review article
- Published by Elsevier in Fibrinolysis and Proteolysis
- Vol. 12 (5) , 259-276
- https://doi.org/10.1016/s0268-9499(98)80019-2
Abstract
No abstract availableThis publication has 78 references indexed in Scilit:
- The effects of genotype and infant weight on adult plasma levels of fibrinogen, factor VII, and LDL cholesterol are additive.Journal of Medical Genetics, 1997
- Prospective study of endogenous tissue plasminogen activator and risk of strokeThe Lancet, 1994
- The genetic contribution to the risk of thrombosis and cardiovascular diseaseTrends in Cardiovascular Medicine, 1994
- New alleles in F7 VNTRHuman Molecular Genetics, 1994
- Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart diseaseAtherosclerosis, 1992
- Allelic dimorphism in the human tissue-type plasminogen activator (TPA) gene as a result of an Alu insertion/deletion eventHuman Genetics, 1992
- Hypertriglyceridemia and regulation of fibrinolytic activity.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1992
- Elevation of factor VII activity and mass in coronary artery disease of varying severityClinical Cardiology, 1991
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Fibrinogen as a Risk Factor for Stroke and Myocardial InfarctionNew England Journal of Medicine, 1984